- Q1. What is the business of Gaudium IVF & Women Health Limited?
It is a fertility and women’s health services provider operating a hub‑and‑spoke network of assisted reproductive technology clinics across India, offering IVF, ICSI, IUI and related care. - Q2. Why is the company raising funds via IPO?
Gaudium IVF is raising funds via IPO to expand its centre network, set up new IVF clinics, and reduce borrowings. - Q3. What is the size of the issue and where will it list?
The issue size of the IPO is approx ~2.08 crore equity shares. It will be listed on the BSE & NSE platform. - Q4. What are the risks to an investor?
Key risks include sector regulatory changes, competition, execution challenges in expanding clinics and sensitivity to operational/medical outcomes. - Q5. What are the potential upsides?
Upsides include strong growth potential from rising infertility treatment demand in India, expanding patient reach and scaling of pan‑India services. - Q6. How to apply for the IPO?
You can apply through your broker or bank’s ASBA/UPI facility once the subscription window opens. - Q 7. When is the tentative listing date?
Expected listing date is yet to be announced.
Upcoming
Gaudium IVF & Women Health Limited
0
IPO Score
0
*Score varies on actual price
Gaudium IVF & Women Health Limited is a healthcare company specialising in fertility treatments and women’s reproductive health services, including In Vitro Fertilisation (IVF), ICSI, IUI, and comprehensive gynaecological care delivered through a network of centres across India – a business aimed at facilitating assisted conception and related medical support for patients. The company has filed its Draft Red Herring Prospectus with SEBI for an IPO comprises of fresh issue of approximately 1.14 crore equity shares and OFS of about 0.95 crore equity shares by the promoter.
Gaudium IVF & Women Health Limited was incorporated in the year 2009.Dr. Manika Khanna is the Founder, Chairperson & Managing Director (MD/CEO) of the company.
It offers comprehensive assisted reproductive technologies such as IVF, ICSI, IUI, blastocyst culture, cryopreservation (egg/embryo/sperm freezing), and specialised infertility treatments for both female and male reproductive disorders.
It operates a network of approximately 36 state‑of‑the‑art centres across six Indian states, serving thousands of patients domestically and internationally, and holds significant brand recognition in the IVF sector.
Subscription date to apply for Gaudium IVF & Women Health Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
|
Year
|
2025
|
|---|---|
|
Networth
|
₹ 46.3Cr
|
|
Revenue
|
₹ 70.7 Cr
|
|
EBITDA
|
₹ 28.6 Cr
|
|
PAT
|
₹ 19.1 Cr
|
|
EBITDA Margin
|
~40.48%
|
|
PAT Margin
|
~26.96%
|
|
Face Value
|
Rs.05 per Equity Share
|
IPO Important Dates
|
#
|
Date
|
|---|---|
|
Open Date
|
TBA
|
|
Close Date
|
TBA
|
|
Anchor Investor Bidding
|
TBA
|
|
Allotment Date
|
TBA
|
|
Refunds& Demat Credit
|
TBA
|
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
|
Purpose
|
Amount
|
|---|---|
|
Borrowing prepayment
|
~ ₹ 20 Cr
|
|
Establishing New IVF centers
|
~ ₹ 50 Cr
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
General Corporate Purpose
|
Balance
|
Financial Data
|
#
|
2023
|
2024
|
2025
|
|---|---|---|---|
|
Revenue (₹ Cr)
|
44.23
|
47.89
|
70.72
|
|
PAT (₹ Cr)
|
13.52
|
10.31
|
19.12
|
|
Asset (₹ Cr)
|
36.62
|
51.01
|
88.51
|
|
Net Worth (₹ Cr)
|
22.72
|
26.98
|
46.29
|
IPO Grey Market Premium
|
Date
|
IPO Price
|
IPO GMP
|
Profit Per Lot
|
|---|---|---|---|
|
08-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
07-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
06-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
05-Aug
|
₹ –
|
₹ –
|
₹ –
|
|
04-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
|
Promoters
|
% Shares
|
|---|---|
|
Dr. Manika Khanna
|
~99.32%
|
|
Dr. Peeyush Khanna
|
~0.36%
|
|
Vishad Khanna
|
~0.30%
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
Lot Size details
|
Application Type
|
Lot Size
|
No. of Lot
|
No. of Shares
|
Investment Amount
|
|---|---|---|---|---|
|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
|
ROE
|
00
|
|---|---|
|
ROCE
|
00
|
|
RoNW
|
00
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
